Late Vistra After 250% Run: Is It Finally Too Late to Buy?
Vistra surged dramatically, but does the rally leave room for gains or is the stock now a trap for late buyers? This ...
Mitigating spending issues involves straightforward strategies. Apply small, consistent changes to protect the budget and increase savings.
13,785 articlesVistra surged dramatically, but does the rally leave room for gains or is the stock now a trap for late buyers? This ...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...
A Utah mother of three stands trial for murder after a year of tragedy, with prosecutors alleging a fentanyl-linked d...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
KXI powers higher on risk-off flows, yet currency swings across Nestlé, Coca-Cola, Walmart and other holdings threate...
In today’s Morning Minute, Circle earnings take center stage as crypto markets rally. Stablecoins anchor liquidity wh...
CoreWeave faced a sharp move after its latest earnings, with shares slipping in after-hours trading despite a top-lin...
The cyber threat landscape is expanding, and AI is changing the game. This article explains why the cybersecurity mar...
In 2025, Interactive Brokers stayed focused on the engine that powers long-term success: scale, discipline, and momen...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...